Search results
New biomarker identified to diagnose Alzheimer's in asymptomatic stages
Medical Xpress· 6 hours agoMolecular Basis of Disease. The search for biomarkers that are stable and easily detectable in...
The Stages of Dementia, Explained
Health.com· 5 days agoThe most common cause of dementia is Alzheimer’s disease. Unfortunately, dementia is progressive, meaning it worsens over time. Over that time, you or...
A gene long thought to just raise the risk for Alzheimer's may cause some cases
The Daily Progress· 6 days agoFor the first time, researchers have identified a genetic form of late-in-life Alzheimer's disease.
...LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early ...
The Woonsocket Call· 22 hours agoFood and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: LEQEMBI®) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation by the FDA ...
Alzheimer's Drug Discovery Foundation (ADDF) and Association for Frontotemporal Degeneration (AFTD)...
WFRV 5 Green Bay· 2 days agoThe Alzheimer's Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) announced today the extension of the Treat FTD ...
Expert Q&A: Alzheimer’s Risk and the APOE4 Gene
WebMD· 6 days agoWith two APOE4 genes, you’re almost certain to developAlzheimer’s, and you’ll likely start getting symptoms at an earlier age, according to new findings published in Nature ...
Patients Fare Better When They Get Palliative Care Sooner, Not Later
Scientific American· 1 day agoIn the last months of my mother’s life, before she went into hospice, she was seen at home by a...
More than 20,000 people join search for new dementia treatments
PA Media: Science via Yahoo News· 2 days ago“It will allow us to match individuals to particular studies and speed up the development of...
Alzheimer’s vaccine licensing deal boosts AC Immune
Market Watch· 2 days agoThe deal gives Japanese drugmaker Takeda the exclusive option to license global rights to the vaccine, known as ACI-24.060, which is designed to delay or...
What to Consider When Prescribing Lecanemab
Medscape· 6 days agoClinicians interested in treating patients with symptoms of mild cognitive impairment or mild dementia should carefully analyze the potential benefits and harms of monoclonal ...
